Schedule 13D ownership disclosure

Windtree Therapeutics Inc

Security class unavailable · CUSIP: 97382D204

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,311,604
Percent of class
62.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-18-006232
Form type
SC 13D/A
Filer
Lee's Pharmaceutical Holdings Ltd
CIK
CIK 1722778
Filed
May 15, 2018
Reporting period
—
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub